Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.

Identifieur interne : 000160 ( Ncbi/Curation ); précédent : 000159; suivant : 000161

Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.

Auteurs : Tami L. Raguse [États-Unis] ; Emilie A. Porter ; Bernard Weisblum ; Samuel H. Gellman

Source :

RBID : pubmed:12392424

Descripteurs français

English descriptors

Abstract

Antimicrobial alpha-helical alpha-peptides are part of the host-defense mechanism of multicellular organisms and could find therapeutic use against bacteria that are resistant to conventional antibiotics. Recent work from Hamuro et al. has shown that oligomers of beta-amino acids ("beta-peptides") that can adopt an amphiphilic helix defined by 14-membered ring hydrogen bonds ("14-helix") are active against Escherichia coli [Hamuro, Y.; Schneider, J. P.; DeGrado, W. F. J. Am. Chem. Soc. 1999, 121, 12200-12201]. We have created two series of cationic 9- and 10-residue amphiphilic beta-peptides to probe the effect of 14-helix stability on antimicrobial and hemolytic activity. 14-Helix stability within these series is modulated by varying the proportions of rigid trans-2-aminocyclohexanecarboxylic acid (ACHC) residues and flexible acyclic residues. We have previously shown that a high proportion of ACHC residues in short beta-peptides encourages 14-helical structure in aqueous solution [Appella, D. H.; Barchi, J. J.; Durell, S. R.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 2309-2310]. Circular dichroism of the beta-peptides described here reveals a broad range of 14-helix population in aqueous buffer, but this variation in helical propensity does not lead to significant changes in antibiotic activity against a set of four bacteria. Several of the 9-mers display antibiotic activity comparable to that of a synthetic magainin derivative. Among these 9-mers, hemolytic activity increases slightly with increasing 14-helical propensity, but all of the 9-mers are less hemolytic than the magainin derivative. Previous studies with conventional peptides (alpha-amino acid residues) have provided conflicting evidence on the relationship between helical propensity and antimicrobial activity. This uncertainty has arisen because alpha-helix stability can be varied to only a limited extent among linear alpha-peptides without modifying parameters important for antimicrobial activity (e.g., net charge or hydrophobicity); a much greater range of helical stability is accessible with beta-peptides. For example, it is very rare for a linear alpha-peptide to display significant alpha-helix formation in aqueous solution and manifest antibacterial activity, while the linear beta-peptides described here range from fully unfolded to very highly folded in aqueous solution. This study shows that beta-peptides can be unique tools for analyzing relationships between conformational stability and biological activity.

DOI: 10.1021/ja0270423
PubMed: 12392424

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:12392424

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.</title>
<author>
<name sortKey="Raguse, Tami L" sort="Raguse, Tami L" uniqKey="Raguse T" first="Tami L" last="Raguse">Tami L. Raguse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry and Department of Pharmacology, University of Wisconsin, Madison 53706, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Department of Pharmacology, University of Wisconsin, Madison 53706</wicri:regionArea>
<wicri:noRegion>Madison 53706</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Porter, Emilie A" sort="Porter, Emilie A" uniqKey="Porter E" first="Emilie A" last="Porter">Emilie A. Porter</name>
</author>
<author>
<name sortKey="Weisblum, Bernard" sort="Weisblum, Bernard" uniqKey="Weisblum B" first="Bernard" last="Weisblum">Bernard Weisblum</name>
</author>
<author>
<name sortKey="Gellman, Samuel H" sort="Gellman, Samuel H" uniqKey="Gellman S" first="Samuel H" last="Gellman">Samuel H. Gellman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12392424</idno>
<idno type="pmid">12392424</idno>
<idno type="doi">10.1021/ja0270423</idno>
<idno type="wicri:Area/PubMed/Corpus">002486</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002486</idno>
<idno type="wicri:Area/PubMed/Curation">002486</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002486</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002349</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002349</idno>
<idno type="wicri:Area/Ncbi/Merge">000160</idno>
<idno type="wicri:Area/Ncbi/Curation">000160</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.</title>
<author>
<name sortKey="Raguse, Tami L" sort="Raguse, Tami L" uniqKey="Raguse T" first="Tami L" last="Raguse">Tami L. Raguse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry and Department of Pharmacology, University of Wisconsin, Madison 53706, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Department of Pharmacology, University of Wisconsin, Madison 53706</wicri:regionArea>
<wicri:noRegion>Madison 53706</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Porter, Emilie A" sort="Porter, Emilie A" uniqKey="Porter E" first="Emilie A" last="Porter">Emilie A. Porter</name>
</author>
<author>
<name sortKey="Weisblum, Bernard" sort="Weisblum, Bernard" uniqKey="Weisblum B" first="Bernard" last="Weisblum">Bernard Weisblum</name>
</author>
<author>
<name sortKey="Gellman, Samuel H" sort="Gellman, Samuel H" uniqKey="Gellman S" first="Samuel H" last="Gellman">Samuel H. Gellman</name>
</author>
</analytic>
<series>
<title level="j">Journal of the American Chemical Society</title>
<idno type="ISSN">0002-7863</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-Bacterial Agents (chemistry)</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Bacillus subtilis (drug effects)</term>
<term>Circular Dichroism</term>
<term>Drug Design</term>
<term>Drug Stability</term>
<term>Enterococcus faecalis (drug effects)</term>
<term>Escherichia coli (drug effects)</term>
<term>Microbial Sensitivity Tests</term>
<term>Oligopeptides (chemical synthesis)</term>
<term>Oligopeptides (chemistry)</term>
<term>Oligopeptides (pharmacology)</term>
<term>Protein Structure, Secondary</term>
<term>Staphylococcus aureus (drug effects)</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antibactériens ()</term>
<term>Antibactériens (pharmacologie)</term>
<term>Bacillus subtilis ()</term>
<term>Conception de médicament</term>
<term>Dichroïsme circulaire</term>
<term>Enterococcus faecalis ()</term>
<term>Escherichia coli ()</term>
<term>Oligopeptides ()</term>
<term>Oligopeptides (pharmacologie)</term>
<term>Oligopeptides (synthèse chimique)</term>
<term>Relation structure-activité</term>
<term>Stabilité de médicament</term>
<term>Staphylococcus aureus ()</term>
<term>Structure secondaire des protéines</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Bacillus subtilis</term>
<term>Enterococcus faecalis</term>
<term>Escherichia coli</term>
<term>Staphylococcus aureus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibactériens</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Circular Dichroism</term>
<term>Drug Design</term>
<term>Drug Stability</term>
<term>Microbial Sensitivity Tests</term>
<term>Protein Structure, Secondary</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Antibactériens</term>
<term>Bacillus subtilis</term>
<term>Conception de médicament</term>
<term>Dichroïsme circulaire</term>
<term>Enterococcus faecalis</term>
<term>Escherichia coli</term>
<term>Oligopeptides</term>
<term>Relation structure-activité</term>
<term>Stabilité de médicament</term>
<term>Staphylococcus aureus</term>
<term>Structure secondaire des protéines</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Antimicrobial alpha-helical alpha-peptides are part of the host-defense mechanism of multicellular organisms and could find therapeutic use against bacteria that are resistant to conventional antibiotics. Recent work from Hamuro et al. has shown that oligomers of beta-amino acids ("beta-peptides") that can adopt an amphiphilic helix defined by 14-membered ring hydrogen bonds ("14-helix") are active against Escherichia coli [Hamuro, Y.; Schneider, J. P.; DeGrado, W. F. J. Am. Chem. Soc. 1999, 121, 12200-12201]. We have created two series of cationic 9- and 10-residue amphiphilic beta-peptides to probe the effect of 14-helix stability on antimicrobial and hemolytic activity. 14-Helix stability within these series is modulated by varying the proportions of rigid trans-2-aminocyclohexanecarboxylic acid (ACHC) residues and flexible acyclic residues. We have previously shown that a high proportion of ACHC residues in short beta-peptides encourages 14-helical structure in aqueous solution [Appella, D. H.; Barchi, J. J.; Durell, S. R.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 2309-2310]. Circular dichroism of the beta-peptides described here reveals a broad range of 14-helix population in aqueous buffer, but this variation in helical propensity does not lead to significant changes in antibiotic activity against a set of four bacteria. Several of the 9-mers display antibiotic activity comparable to that of a synthetic magainin derivative. Among these 9-mers, hemolytic activity increases slightly with increasing 14-helical propensity, but all of the 9-mers are less hemolytic than the magainin derivative. Previous studies with conventional peptides (alpha-amino acid residues) have provided conflicting evidence on the relationship between helical propensity and antimicrobial activity. This uncertainty has arisen because alpha-helix stability can be varied to only a limited extent among linear alpha-peptides without modifying parameters important for antimicrobial activity (e.g., net charge or hydrophobicity); a much greater range of helical stability is accessible with beta-peptides. For example, it is very rare for a linear alpha-peptide to display significant alpha-helix formation in aqueous solution and manifest antibacterial activity, while the linear beta-peptides described here range from fully unfolded to very highly folded in aqueous solution. This study shows that beta-peptides can be unique tools for analyzing relationships between conformational stability and biological activity.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000160 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000160 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:12392424
   |texte=   Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:12392424" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021